For instance, in non–small cell lung carcinoma (NSCLC), CAF-derived exosomal miR-210 can promote EMT by targeting UPF1 and activating the PTEN/PI3K/AKT pathway and therefore can accelerate the growth of NSCLC (20). This evidence concerns the gene UPF1 and non-small cell lung carcinoma.